Intensity Therapeutics
(NASDAQ) INTS
Intensity Therapeutics Financials at a Glance
Market Cap
$16.04M
Revenue (TTM)
$0.00
Net Income (TTM)
$11.74M
EPS (TTM)
$-15.86
P/E Ratio
-0.40
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.08
Volume
23,300.752
Open
$6.28
Price
$6.08
Volume
23,300.752
Open
$6.28
Previous Close
$6.33
Daily Range
$6.00 - $6.34
52-Week Range
$4.63 - $54.50
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$6.08
Volume
23,300.752
Open
$6.28
Previous Close
$6.33
Daily Range
$6.00 - $6.34
52-Week Range
$4.63 - $54.50
INTS News
INTS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Intensity Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
16
CEO
Lewis H. Bender, MBA
Headquarters
Westport, CT 06880, US
INTS Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-235%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-2.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$16.04M
Shares Outstanding
2.53M
Volume
23.30K
Short Interest
0.00%
Avg. Volume
57.29K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$16.59M
EBITDA
$16.27M
Operating Cash Flow
$15.22M
Capital Expenditure
$0.00
Free Cash Flow
$15.22M
Cash & ST Invst.
$2.59M
Total Debt
$138.00K
Intensity Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$6.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$16.04M
N/A
Market Cap/Employee
$3.21M
N/A
Employees
5
N/A
Net Income
$2.67M
+24.0%
EBITDA
$62.00K
+101.8%
Quarterly Fundamentals
Net Cash
$6.95M
+163.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$87.00K
-25.6%
Short Term Debt
$31.00K
+10.7%
Return on Assets
-1.22%
N/A
Return on Invested Capital
-1.65%
N/A
Free Cash Flow
$2.39M
+39.9%
Operating Cash Flow
$2.39M
+39.9%